At the conclusion of this activity, participants will be able to:
1. Identify two specific forms of medical mistrust that can be addressed by clinicians (e.g. belief in doctors as drug pushers incentivized by pharmaceutical companies and belief that placebos are often given to minority patients on clinical trials).
2. Identify common modifiable barriers that impact ethnic minorities (e.g. social support through support groups or patient advocates or home care services or insurance enrollment through critical treatment periods or language).
This educational series is supported by independent educational grants from:
Astellas
AstraZeneca
Bayer
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Merck & Co., Inc.
Pfizer, Inc.